E. Premkumar Reddy

21.4k citations

203 papers · 17.2k indexed · 8 hit papers · h-index 63

Impact in

Oncology top 0.2%
- Cancer-related Molecular Pathways
- Cytokine Signaling Pathways and Interactions
Molecular Biology top 0.2%
- Ubiquitin and proteasome pathways
- Protein Kinase Regulation and GTPase Signaling
- PI3K/AKT/mTOR signaling in cancer

Papers in

Oncology 72
- Cancer-related Molecular Pathways 30
- Cytokine Signaling Pathways and Interactions 15
Hematology 26
- Chronic Myeloid Leukemia Treatments 15

Co-authors: Danny N. Dhanasekaran Xavier Graña Sushil G. Rane Stacey J. Baker Mariano Barbacid Eugenio Santos Stuart A. Aaronson Roberta K. Reynolds
Journals: Proceedings of the National Academy of Sciences (22 papers)Oncogene (21 papers)Cancer Research (14 papers)Blood (11 papers)Science (9 papers)
Partner nations: United States Canada Japan

In The Last Decade

E. Premkumar Reddy

201 papers receiving 16.3k citations

Hit Papers

8 papers align trajectories log scale

Drugging the 'undruggable' cancer targets 2017 · 636 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Nature reviews. Cancer
2008 Oncogene
1999 Nature Genetics
1995 PubMed
1984 Science
1982 Proceedings of the National Academy of Sciences
1982 Nature
1982 Nature

Peers

Countries citing papers authored by E. Premkumar Reddy

Since Specialization

Citations

This map shows the geographic impact of E. Premkumar Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Premkumar Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Premkumar Reddy more than expected).

Fields of papers citing papers by E. Premkumar Reddy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Premkumar Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Premkumar Reddy. The network helps show where E. Premkumar Reddy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside E. Premkumar Reddy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Premkumar Reddy Line = papers co-authored together E. Premkumar Reddy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma Cancer Research ·Deepak Perumal, Hadab Al Qtame, Violetta V. Leshchenko, Zewei Jiang, Sai Krishna Athaluri Divakar, Hearn Jay Cho, Ajai Chari, Joshua Brody, M. V. Ramana Reddy, Weijia Zhang, E. Premkumar Reddy, Sundar Jagannath, Samir Parekh	2016	27
2	Combined Administration of Rituximab and ON 013105 Induces Apoptosis in Mantle Cell Lymphoma Cells and Reduces Tumor Burden in a Mouse Model of Mantle Cell Lymphoma Clinical Cancer Research ·Anil Prasad, Ashutosh Shrivastava, Evangelos Papadopoulos, Paula M. Kuzontkoski, M. V. Ramana Reddy, Amanda M. Gillum, Ramesh Kumar, E. Premkumar Reddy, Jerome E. Groopman	2012	4
3	Progenitor/stem cells give rise to liver cancer due to aberrant TGF-β and IL-6 signaling Proceedings of the National Academy of Sciences ·Yi Tang, Krit Kitisin, Wilma Jogunoori, Cuiling Li, Chu‐Xia Deng, Susette C. Mueller, Habtom W. Ressom, Asif Rashid, Aiwu Ruth He, Jonathan Mendelson, J. Milburn Jessup, Kirti Shetty, Michael Zasloff, Bibhuti Mishra, E. Premkumar Reddy, Lynt B. Johnson, Lopa Mishra	2008	243
4	CDK4 is an important target for hepatocellular cancer with inactivation of TGF-beta signaling through Smad and ELF Cancer Research ·Michael J. Pishvaian, Geeta Upadhyay, Zhixing Yao, Young Tae Kim, Anders Hildeman, Gonzalez Felicity, Krit Kitisin, Eugene A. Volpe, Michael H. Woodbury, Sang Wun Kim, Ravi Babu B, Anthony D. Kang, Hong Xie, E. Premkumar Reddy, Lopa Mishra	2008	2
5	p21 Loss Cooperates with INK4 Inactivation Facilitating Immortalization and Bcl-2 –Mediated Anchorage-Independent Growth of Oncogene-Transduced Primary Mouse Fibroblasts Cancer Research ·Christopher J. Carbone, Xavier Graña, E. Premkumar Reddy, Dale S. Haines	2007	8
6	Cross-resistance to ON01910.Na among drug-resistant human tumor cell lines Cancer Research ·Adrian Preda, Takao Ohnuma, Jian‐Dong Jiang, James F. Holland, E. Premkumar Reddy	2006	3
7	Transforming Growth Factor-β Suppresses Nonmetastatic Colon Cancer through Smad4 and Adaptor Protein ELF at an Early Stage of Tumorigenesis Cancer Research ·Yi Tang, Varalakshmi Katuri, Radhika Srinivasan, Franz Fogt, Robert S. Redman, Ace Spitzer, Anders Hildeman, Thomas Fishbein, Michael Zasloff, E. Premkumar Reddy, Bibhuti Mishra, Lopa Mishra	2005	74
8	A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance Proceedings of the National Academy of Sciences ·Kiranmai Gumireddy, Stacey J. Baker, Stephen C. Cosenza, À Libourne, Anthony D. Kang, Kimberly A. Robell, M. V. Ramana Reddy, E. Premkumar Reddy	2005	172
9	Cytotoxicity and Radiosensitization in Cervical Carcinoma Cells by ON01910, a Novel Polo-Like Kinase 1 Inhibitor International Journal of Radiation OncologyBiologyPhysics ·K. Saravanakumar, Derek Blythe, Anand Sharma, Shalin Shah, M. A. Seyedabbasi, Amauri Alcindo Alfieri, David E. Bernal Neira, Shalom Kalnicki, M. V. Ramana Reddy, Stanley C. Bell, E. Premkumar Reddy, Chandan Guha	2005	1
10	Solvent Dependent Dehydrating Condensation of Benzylsulfonyl Acetic Acids Synthetic Communications ·A. Díaz-Sánchez, E. Premkumar Reddy, M. V. Ramana Reddy	2004	5
11	Human follicle-stimulating hormone receptor (FSH-R) promoter/enhancer activity is inhibited by transcriptional factors, from the upstream stimulating factors family, via E-box and newly identified initiator element (Inr) in FSH-R non-expressing cells Gynecological Endocrinology ·GIARNO GIARNO, S Panzera, Clement Lee, E. Premkumar Reddy, �. G. Mirkamalova	2004	8
12	Molecular Mechanisms Associated with the Regulation of Apoptosis by the Two Alternatively Spliced Products of c-Myb Molecular and Cellular Biology ·Atul Kumar, Stacey J. Baker, Clement Lee, E. Premkumar Reddy	2003	20
13	The T Cell-Dependent B Cell Immune Response and Germinal Center Reaction Are Intact in A-myb-Deficient Mice The Journal of Immunology ·Kalpit A. Vora, Vicky M. Lentz, Д. В. Вовкотруб, Sambasiva P. Rao, Richard V. Mettus, A Toscani, E. Premkumar Reddy, Tim Manser	2001	4
14	Cloning of murine G1RP, a novel gene related to Drosophila melanogaster g1 Gene ·Stacey J. Baker, E. Premkumar Reddy	2000	8
15	Janus kinases: components of multiple signaling pathways Oncogene ·Sushil G. Rane, E. Premkumar Reddy	2000	370
16	The C-Terminal Domain of B-Myb Acts As a Positive Regulator of Transcription and Modulates Its Biological Functions Molecular and Cellular Biology ·Il‐Hoan Oh, E. Premkumar Reddy	1998	20
17	Arrest of spermatogenesis and defective breast development in mice lacking A-myb Nature ·A Toscani, Richard V. Mettus, Robert Coupland, Henry Simpkins, Judith Litvin, Joanne M. Orth, Kimi S. Hatton, E. Premkumar Reddy	1997	189
18	Overexpression of C-Terminally but Not N-Terminally Truncated Myb Induces Fibrosarcomas: a Novel Nonhematopoietic Target cell for the myb Oncogene Molecular and Cellular Biology ·Richard D. Press, E. Premkumar Reddy, Donald L. Ewert	1994	5
19	The Galactosyl Ceramide/Sulfatide Receptor Binding Region of HIV-1 gp120 Maps to Amino Acids 206-275 AIDS Research and Human Retroviruses ·Shama Bhat, Richard V. Mettus, E. Premkumar Reddy, Kenneth E. Ugen, David Lyle, William V. Williams, David B. Weiner	1993	75
20	A Cloned cDNA Probe for Rat Immunoglobulin Epsilon Heavy Chain: Construction, Identification, and DNA Sequence DNA ·Wayne Kindsvogel, E. Premkumar Reddy, Abdulgaffar Doddamani et al. Abdulgaffar Doddamani et al., Charles Faust	1982	3

About E. Premkumar Reddy

E. Premkumar Reddy is a scholar working on Oncology, Hematology, Genetics, Molecular Biology and Immunology, having authored 203 papers that have together received 17.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (30 papers), Virus-based gene therapy research (17 papers), Chronic Lymphocytic Leukemia Research (15 papers), Microtubule and mitosis dynamics (15 papers), Ubiquitin and proteasome pathways (15 papers), Cytokine Signaling Pathways and Interactions (15 papers), Chronic Myeloid Leukemia Treatments (15 papers) and RNA and protein synthesis mechanisms (14 papers). The work is most often cited by research in Oncology (4.8k citations), Molecular Biology (10.4k citations), Cancer Research (2.1k citations), Hematology (1.5k citations) and Immunology (2.7k citations). E. Premkumar Reddy has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Danny N. Dhanasekaran, Xavier Graña, Sushil G. Rane, Stacey J. Baker, Mariano Barbacid, Eugenio Santos, Stuart A. Aaronson, Roberta K. Reynolds, Il‐Hoan Oh and Keith C. Robbins. Their work appears in journals such as Proceedings of the National Academy of Sciences, Oncogene, Cancer Research, Blood and Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact